Hifibio Therapeutics
Clinical trials sponsored by Hifibio Therapeutics, explained in plain language.
-
New Two-Drug combo enters human testing for Tough-to-Treat cancers
Disease control OngoingThis is an early-stage study to find a safe dose of a new drug called HFB200603, given alone or with an existing immunotherapy (tislelizumab), for people with advanced cancers that have stopped responding to standard treatments. The trial will enroll about 83 adults with specific…
Phase: PHASE1 • Sponsor: HiFiBiO Therapeutics • Aim: Disease control
Last updated Apr 03, 2026 14:41 UTC
-
New cancer drug enters first human trials for Tough-to-Treat tumors
Disease control OngoingThis is an early-stage study to find a safe dose of a new immunotherapy drug called HFB200301. It is being tested alone and in combination with an existing drug (tislelizumab) in adults with advanced solid tumors who have already tried other treatments. The main goal is to see ho…
Phase: PHASE1 • Sponsor: HiFiBiO Therapeutics • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC